Bio Essence Corporation
Bio Essence Corporation engages in the manufacturing and distributing health supplement products. It also offers original equipment manufacturing services. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.
Bio Essence Corporation (BIOE) - Total Assets
Latest total assets as of September 2025: $184.53K USD
Based on the latest financial reports, Bio Essence Corporation (BIOE) holds total assets worth $184.53K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bio Essence Corporation - Total Assets Trend (2017–2024)
This chart illustrates how Bio Essence Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bio Essence Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
Bio Essence Corporation's total assets of $184.53K consist of 99.9% current assets and 0.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.5% |
| Accounts Receivable | $5.12K | 1.8% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $332.00 | 0.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Bio Essence Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bio Essence Corporation's current assets represent 99.9% of total assets in 2024, an increase from 91.5% in 2017.
- Cash Position: Cash and equivalents constituted 0.5% of total assets in 2024, down from 37.8% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 1.8% of total assets.
Bio Essence Corporation Competitors by Total Assets
Key competitors of Bio Essence Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Bio Essence Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Bio Essence Corporation generates 1.15x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Bio Essence Corporation is currently not profitable relative to its asset base.
Bio Essence Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.06 | 0.23 | 0.17 |
| Quick Ratio | 0.06 | 0.23 | 0.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.05 Million | $ -2.35 Million | $ -1.57 Million |
Bio Essence Corporation - Advanced Valuation Insights
This section examines the relationship between Bio Essence Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 8.12 |
| Asset Growth Rate (YoY) | -89.4% |
| Total Assets | $281.02K |
| Market Capitalization | $2.28 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Bio Essence Corporation's assets at a significant premium ( 8.12x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Bio Essence Corporation's assets decreased by 89.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Bio Essence Corporation (2017–2024)
The table below shows the annual total assets of Bio Essence Corporation from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $281.02K | -89.44% |
| 2023-12-31 | $2.66 Million | +71.98% |
| 2022-12-31 | $1.55 Million | -8.92% |
| 2021-12-31 | $1.70 Million | -7.93% |
| 2020-12-31 | $1.85 Million | -19.58% |
| 2019-12-31 | $2.29 Million | +124.48% |
| 2018-12-31 | $1.02 Million | -45.79% |
| 2017-12-31 | $1.89 Million | -- |